Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival

Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival

US Patent 9528982 · Granted Dec 27, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Microrna assay for detection and management of pancreatic cancer precursors2025
Theranostic tools for management of pancreatic cancer and its precursors2025
MicroRNA assay for detection and management of pancreatic cancer precursors2024
Compositions and methods APC, CREB, and BAD pathways to assess and affect cancer2021
Biomarkers and methods for predicting benefit of adjuvant chemotherapy2019
MicroRNA assay for detection and management of pancreatic cancer precursors2019
Method of diagnosing, treating and determining progression and survival of cance2018
Method of diagnosing, treating and determining progression and survival of cance2018
O-glycan pathway ovarian cancer signature2017
O-glycan pathway ovarian cancer signature2017
Method of predicting chemotherapeutic responsiveness of cancer2016
Malignancy-risk signature from histologically normal breast tissue2015